InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,543.22
(
1.61%
)
US TECH 100
18,976.80
(
0.00%
)
Dow Jones
40,563.06
(
1.39%
)
Brent Oil
80.27
(
-0.27%
)
Bitcoin
58,531.36
(
1.72%
)
Post# of 252897
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

NP1986

Send PM Follow Ignore
Followers 6
Posts 541
Boards Moderated 0
Alias Born 06/07/2011

NP1986

Re: rkrw post# 125942

Tuesday, 08/30/2011 11:27:12 PM

Tuesday, August 30, 2011 11:27:12 PM

Post# of 252897

There have also been CR's reported with Abraxane.



An Abraxane/gemcitabine combo study had three CRs (4%):
http://www.medicalnewstoday.com/releases/185903.php

So yes, it would make interpreting the results of the single-arm study difficult - unless the results are overwhelming.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up